Towards a druggable epitranscriptome: Compounds that target RNA modifications in cancer-Reference-Cited by-同舟云学术

Towards a druggable epitranscriptome: Compounds that target RNA modifications in cancer

Published:2021-07-27 Issue: Volume: Page:
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Berdasco María¹²^ORCID,Esteller Manel³⁴⁵⁶^ORCID

Affiliation:

1. Epigenetic Therapies Group, Experimental and Clinical Hematology Program (PHEC) Josep Carreras Leukaemia Research Institute Barcelona Spain

2. Cancer Epigenetics and Biology Program (PEBC) Bellvitge Biomedical Research Institute (IDIBELL) Barcelona Spain

3. Cancer Epigenetics Group, Cancer and Leukemia Epigenetics and Biology Program (PEBCL) Josep Carreras Leukaemia Research Institute (IJC) Barcelona Spain

4. Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain

5. Physiological Sciences Department, School of Medicine and Health Sciences University of Barcelona Barcelona Spain

6. Institució Catalana de Recerca i Estudis Avançats (ICREA) Barcelona Spain

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15604

Reference156 articles.

1. HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events

2. N6-methyladenosine marks primary microRNAs for processing

3. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors

4. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors

5. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. tRNA modification profiling reveals epitranscriptome regulatory networks inPseudomonas aeruginosa;2024-07-02

2. Mass Spectrometry-Based Pipeline for Identifying RNA Modifications Involved in a Functional Process: Application to Cancer Cell Adaptation;Analytical Chemistry;2024-01-26

3. Epigenetic Restriction Factors (eRFs) in Virus Infection;Viruses;2024-01-25

4. Targeting epitranscriptomics for novel drug development;Biochemical and Molecular Pharmacology in Drug Discovery;2024

5. Novel targets in drug discovery;Pharmacognosy;2024